IFN-γ is a major player in anti-tumor immunity, and exerts anti-proliferative and pro-apoptotic effects in tumor cells [57,58,59,60], recruits immune cells into the tumor microenvironment [61,62], and enhances the tumoricidal activities of innate and adaptive immune cells [63,64,65]. The gene discussed is IFNG; the disease is neoplasm.